Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

China · Delayed Price · Currency is CNY

10.63

+0.18 (1.72%)

Jul 3, 2026, 3:04 PM CST

-34.34% (1Y)

Market Cap	5.25B -33.9%
Revenue (ttm)	3.01B -0.8%
Net Income	403.78M -21.2%
EPS	0.81 -21.9%
Shares Out	494.11M
PE Ratio	13.19
Forward PE	7.23
Dividend	0.40 (3.76%)
Ex-Dividend Date	May 28, 2026

Volume	7,980,666
Open	9.87
Previous Close	10.45
Day's Range	9.87 - 10.72
52-Week Range	9.26 - 20.66
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 22, 2026

About SHE:300705

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and br... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2001

Employees 2,298

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300705

Full Company Profile

Financial Performance

In 2025, SHE:300705's revenue was 3.11 billion, an increase of 6.15% compared to the previous year's 2.93 billion. Earnings were 472.82 million, a decrease of -7.72%.

Financial Statements